Business

RAD Doses First Patient in RAD 402 Phase 1 Clinical Study

RAD Doses First Patient in RAD 402 Phase 1 Clinical Study

Radiopharm Theranostics LimitedMarch 26, 20265

RAD Doses First Patient in RAD 402 Phase 1 Clinical Study

About this update from Radiopharm Theranostics Limited

Radiopharm Theranostics Ltd has released a press release. View Attachment

View stock analysis, news, and events for Radiopharm Theranostics Limited

More from Radiopharm Theranostics Limited

Radiopharm Theranostics Receives Positive Recommendation from Data Safety and Monitoring Committee to Advance to Cohort 4 in 177Lu-RAD202...

August 20, 2026

RAD advances to Cohort 4 in 177Lu-RAD202 Phase 1 HEAT Trial

August 19, 2026

All Radiopharm Theranostics Limited news →